Literature DB >> 19564411

Receptor density is key to the alpha2/beta interferon differential activities.

Ignacio Moraga1, Daniel Harari, Gideon Schreiber, Gilles Uzé, Sandra Pellegrini.   

Abstract

Multiple type I interferons (IFN-alpha/beta) elicit Jak/Stat activation, rapid gene induction, and pleiotropic effects, such as differentiation, antiviral protection, and blocks in proliferation, which are dependent on the IFN subtype and the cellular context. To date, ligand- and receptor-specific molecular determinants underlying IFN-alpha/beta differential activities or potencies have been well characterized. To analyze cellular determinants that impact subtype-specific potency, human fibrosarcoma U5A-derived clones, exhibiting a gradient of IFN sensitivity by virtue of increasing receptor levels, were monitored for Jak/Stat signaling, gene induction, cell cycle lengthening, and apoptosis. In cells with scarce receptors, IFN-beta was more potent than IFN-alpha2 in antiproliferative activity, while the two subtypes were equipotent in all other readouts. Conversely, in cells with abundant receptors, IFN-alpha2 matched or even surpassed IFN-beta in all readouts tested. Our results suggest that the differential activities of the IFN subtypes are dictated not only by the intrinsic ligand/receptor binding kinetics but also by the density of cell surface receptor components.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564411      PMCID: PMC2725717          DOI: 10.1128/MCB.01808-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  Cell surface trafficking of Fas in NIT-1 cells and dissection of surface and total Fas expression.

Authors:  P Augstein; A Dunger; C Salzsieder; P Heinke; R Kubernath; J Bahr; U Fischer; R Rettig; E Salzsieder
Journal:  Biochem Biophys Res Commun       Date:  2002-01-11       Impact factor: 3.575

2.  Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.

Authors:  J Piehler; G Schreiber
Journal:  J Mol Biol       Date:  1999-11-19       Impact factor: 5.469

3.  Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells.

Authors:  S Vannucchi; Z A Percario; M V Chiantore; P Matarrese; M K Chelbi-Alix; M Fagioli; P G Pelicci; W Malorni; G Fiorucci; G Romeo; E Affabris
Journal:  Oncogene       Date:  2000-10-19       Impact factor: 9.867

4.  Mechanisms of Interferon-alpha induced apoptosis in malignant cells.

Authors:  Lena Thyrell; Sven Erickson; Boris Zhivotovsky; Katja Pokrovskaja; Olle Sangfelt; Juan Castro; Stefan Einhorn; Dan Grandér
Journal:  Oncogene       Date:  2002-02-14       Impact factor: 9.867

5.  A dual role of IFN-alpha in the balance between proliferation and death of human CD4+ T lymphocytes during primary response.

Authors:  Elisabetta Dondi; Gaël Roué; Victor J Yuste; Santos A Susin; Sandra Pellegrini
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

6.  STAT-1 is activated by IL-4 and IL-13 in multiple cell types.

Authors:  I-Ming Wang; Huamao Lin; Samuel J Goldman; Michiko Kobayashi
Journal:  Mol Immunol       Date:  2004-07       Impact factor: 4.407

Review 7.  Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis.

Authors:  M Chawla-Sarkar; D J Lindner; Y-F Liu; B R Williams; G C Sen; R H Silverman; E C Borden
Journal:  Apoptosis       Date:  2003-06       Impact factor: 4.677

8.  SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor.

Authors:  K G Suresh Kumar; Weigang Tang; Abhilash K Ravindranath; William A Clark; Ed Croze; Serge Y Fuchs
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 9.  Tailoring T-cell receptor signals by proximal negative feedback mechanisms.

Authors:  Oreste Acuto; Vincenzo Di Bartolo; Frédérique Michel
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

10.  Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster.

Authors:  G Lutfalla; S J Holland; E Cinato; D Monneron; J Reboul; N C Rogers; J M Smith; G R Stark; K Gardiner; K E Mogensen
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

View more
  56 in total

Review 1.  Cytokine-receptor interactions as drug targets.

Authors:  Gideon Schreiber; Mark R Walter
Journal:  Curr Opin Chem Biol       Date:  2010-07-07       Impact factor: 8.822

2.  Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses.

Authors:  Stephan Wilmes; Polly-Anne Jeffrey; Jonathan Martinez-Fabregas; Maximillian Hafer; Paul K Fyfe; Elizabeth Pohler; Silvia Gaggero; Martín López-García; Grant Lythe; Charles Taylor; Thomas Guerrier; David Launay; Suman Mitra; Jacob Piehler; Carmen Molina-París; Ignacio Moraga
Journal:  Elife       Date:  2021-04-19       Impact factor: 8.140

3.  Stochastic receptor expression determines cell fate upon interferon treatment.

Authors:  Doron Levin; Daniel Harari; Gideon Schreiber
Journal:  Mol Cell Biol       Date:  2011-06-20       Impact factor: 4.272

Review 4.  The molecular basis for differential type I interferon signaling.

Authors:  Gideon Schreiber
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

5.  Type I interferons induce apoptosis by balancing cFLIP and caspase-8 independent of death ligands.

Authors:  Amir Apelbaum; Ganit Yarden; Shira Warszawski; Daniel Harari; Gideon Schreiber
Journal:  Mol Cell Biol       Date:  2012-12-10       Impact factor: 4.272

6.  Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.

Authors:  Marlena M Westcott; Jingfang Liu; Karishma Rajani; Ralph D'Agostino; Douglas S Lyles; Mercedes Porosnicu
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

Review 7.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

8.  Optimized flow cytometry protocol for analysis of surface expression of interleukin-1 receptor types I and II.

Authors:  Filipp Filippovich Vasilyev; Julia Anatolievna Lopatnikova; Sergey Vitalievich Sennikov
Journal:  Cytotechnology       Date:  2013-02-26       Impact factor: 2.058

Review 9.  IFN-α subtypes: distinct biological activities in anti-viral therapy.

Authors:  K Gibbert; J F Schlaak; D Yang; U Dittmer
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 10.  Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation.

Authors:  Jacob Piehler; Christoph Thomas; K Christopher Garcia; Gideon Schreiber
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.